🇲🇾 QSC Peptides Malaysia  ·  Order from QSC →

Buy Tirzepatide in Malaysia

Asia Warehouse CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  4–7 days  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly — the first of its class to exceed 20% in Phase 3. QSC Asia warehouse to Malaysia in 4–7 business days.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Asia Warehouse to Malaysia

From MYR 292 (USD 62) · 4–7 business days. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.

Buy Tirzepatide at QSC →

Malaysia Shipping Details

DestinationDelivery Time
Kuala Lumpur / Selangor4–7 business days
Penang4–7 business days
Johor Bahru4–7 business days
Ipoh, Melaka, Negeri Sembilan5–8 business days
Sabah and Sarawak (East Malaysia)6–10 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT

Tirzepatide — Variants and Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
MYR 292
USD 62 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
MYR 470
USD 100 · Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
MYR 649
USD 138 · Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue and reduces hepatic gluconeogenesis.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4%. First GLP-1 compound to exceed 20% in a published Phase 3 trial.

Available Across Malaysia

QSC ships Tirzepatide from the Asia regional warehouse to all Malaysian states: Kuala Lumpur, Selangor (Shah Alam, Petaling Jaya, Subang Jaya, Klang), Penang (Georgetown), Johor (Johor Bahru), Perak (Ipoh), Negeri Sembilan (Seremban), Melaka, Pahang, Terengganu, Kelantan, Kedah (Alor Setar), Perlis, and East Malaysia (Sabah, Sarawak). Research institutions across Malaysia — UM, UTM, UKM, UPM, USM, Monash Malaysia, Taylor's, XMUM — all within the delivery window. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016, not a reseller. Purity >=99% HPLC, Janoshik COA verifiable at janoshik.com. MYR and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped from QSC Asia regional warehouse.